Intracoronary thrombolysis in evolving myocardial infarction.
After experimental studies in dogs confirmed the feasibility and safety of rapid intracoronary thrombolysis by local infusion of Thrombolysin (streptokinase and plasmin), intracoronary thrombolysis was attempted in 20 patients with evolving myocardial infarction who were hospitalized within 3 hours from the onset of symptoms during the day and within 2 hours at night. Thrombolysin was infused in the immediate vicinity of the site of coronary occlusion using a 0.85 mm outer diameter catheter advanced through the lumen of the Judkins catheter. Reperfusion was achieved in four patients after an average of 43 minutes of Thrombolysin infusion at a rate of 2000 IU/min and in 15 patients after an average of 21 minutes of Thrombolysin infusion at a rate of 4000 IU/min. The failure to open the artery in one patient may have been caused by our inability to advance the infusion catheter close to the site of occlusion. Rethrombosis occurred in one patient 8 days after reperfusion and 2 days after discontinuation of anticoagulants because of a history of chronic alcoholism. Wall motion and perfusion studies showed improvement following reperfusion. Patency of the artery was achieved an average of 4 hours after the onset of symptoms. The need for earlier reperfusion is emphasized.
D000328:Adult; D000818:Animals; D001157:Arterial Occlusive Diseases / Q000209:etiology / Q000601:surgery; D003331:Coronary Vessels / Q000503:physiopathology*; D003402:Creatine Kinase / Q000097:blood; D004285:Dogs; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products; D005340:Fibrinogen; D005341:Fibrinolysin / Q000008:administration & dosage; D005343:Fibrinolytic Agents; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000503:physiopathology*; D005996:Nitroglycerin / Q000008:administration & dosage; D010958:Plasminogen; D012712:Serum Globulins; D013300:Streptokinase / Q000008:administration & dosage; D013997:Time Factors
D005338:Fibrin Fibrinogen Degradation Products; D005343:Fibrinolytic Agents; D012712:Serum Globulins; D005340:Fibrinogen; D010958:Plasminogen; D003402:Creatine Kinase; D013300:Streptokinase; D005341:Fibrinolysin; D005996:Nitroglycerin